Pallas Capital Advisors LLC Gilead Sciences, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.21 Billion
- Q4 2024
A detailed history of Pallas Capital Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 8,150 shares of GILD stock, worth $896,092. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,150
Previous 7,836
4.01%
Holding current value
$896,092
Previous $656,000
14.63%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,090Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.7 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.88 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.64 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.37 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...